Your Location：
Home >
Browse articles >
Mechanism of Astragaloside Ⅳ on db/db Mice with Type 2 Diabetes Mellitus and Non-alcoholic Fatty Liver Disease Based on AMPK Signaling Pathway
Mechanism of Astragaloside Ⅳ on db/db Mice with Type 2 Diabetes Mellitus and Non-alcoholic Fatty Liver Disease Based on AMPK Signaling Pathway
Enhanced Publication- Chinese Journal of Experimental Traditional Medical Formulae Vol. 30, Issue 5, Pages: 72-79(2024)
DOI： 10.13422/j.cnki.syfjx.20232039
Scan QR Code
Full Text(HTML)
Figs( 3 ) Tabs( 4 )
References
Publication Info
Metrics
431
Views
571
Downloads
4
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Molecular Mechanism of Action of Astragaloside Ⅳ in Modulating Pyroptosis to Attenuate Intestinal Ischemia-reperfusion Injury Based on Experimental Validation
Mechanism of Astragaloside Ⅳ in Treating Diabetic Retinopathy Based on Network Pharmacology and Molecular Docking
Molecular Mechanism of Resveratrol Against NAFLD Based on Network Pharmacology
Analysis on Mechanism of Astragali Radix in Treating IgA Nephropathy Based on Network Pharmacology and in Vitro Cell Experiment
Mechanism of Xixintang in Protecting Blood-brain Barrier in Alzheimer's Disease Model Rats Based on AQP4 Polarization
Related Author
CHANG Liya
LENG Yufang
ZHAO Zicen
WANG Yu
XING Yang
LI Dongbin
Naixin YU
Guoqiong LI
Related Institution
The First Clinical Medical College of Lanzhou University
The First Hospital of Lanzhou University
The Institute of Medicinal Plant Development，Chinese Academy of Medical Sciences and Peking Union Medical College
School of Pharmacy，Guangdong Pharmaceutical University
School of Life Sciences and Biopharmaceutics，Guangdong Pharmaceutical University
Map
Chat
